Background: To evaluate the technology of transesophageal echocardiographic guidance of percardiac closure in patients with low weight.
Methods: Forty-two patients with intracardiac defects, aged from two months to five years (median, 18.4 months) and weighted from 4 to 10 kg (median, 8.9 kg), underwent attempted percardiac device closure under transesophageal echocardiographic guidance.
Results: Thirty-nine (93%) patients successfully underwent occlusion, whereas three patients (7.1%) were converted to conventional open-heart surgery. There was no mortality. They were followed up from 3 months to 15 months (median, 9.4 months). First degree atrioventricular block was detected in one patient at the time of discharge. The most common electrocardiogram change was bundle-branch block, which developed in three (7.7%) patients during follow-up. New mild mitral valve regurgitation (MR) was detected in three patients after operation and disappeared in one but remained in two others. Pericardial perfusion and recurrent intubation developed in one patient, respectively. The incidence of late complications is 5.1% (2/39) including low cardiac output syndrome and residual shunt in one patient, and moderate pericardial perfusion in one patient, respectively. No complication such as device dislocation, thrombosis, and obstruction of left or right ventricular outflow tract was found during the follow-up.
Conclusions: This initial success indicates that transesophageal echocardiographic guidance of percardiac device closure will aid in the treatment of intracardiac defects in selected patients weighing less than 10 kg with good early outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jocs.12015 | DOI Listing |
Cardiovasc Eng Technol
January 2025
Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.
The flow convergence method includes calculation of the proximal isovelocity surface area (PISA) and is widely used to classify mitral regurgitation (MR) with echocardiography. It constitutes a primary decision factor for determination of treatment and should therefore be a robust quantification method. However, it is known for its tendency to underestimate MR and its dependence on user expertise.
View Article and Find Full Text PDFJ Cardiothorac Vasc Anesth
December 2024
Department of Cardiovascular Surgery, Mayo Clinic, Scottsdale, AZ.
Objective: Right ventricular failure is a leading cause of mortality among patients with various etiologies of cardiogenic shock. This case series outlines an innovative approach to directly unloading the right ventricle with the Impella LD or 5.5 without crossing the tricuspid valve in cases requiring tricuspid valve repair or replacement.
View Article and Find Full Text PDFEchocardiography
January 2025
Cardiovascular Imaging Unit, Cardiothoracic Department, IRCCS San Raffaele Hospital, Milan, Italy.
J Cardiothorac Surg
December 2024
Department of Cardiology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Background: Right ventricular (RV) function assessment by echocardiography can be challenging due to its complex morphology. Also, increasing use of sedation rather than general anesthesia for transfemoral approach transcatheter aortic valve replacement (TAVR) reduces the need for intraoperative transesophageal echocardiography (TEE). Recent clinical studies have demonstrated the importance of 3-dimensional (3D) echocardiography and a longitudinal strain for RV function assessment.
View Article and Find Full Text PDFCJC Open
December 2024
Division of Cardiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
Background: Mitral annular calcification (MAC) is a common chronic degenerative process of the mitral valve. Thrombus formation on MAC is a rare complication that likely contributes to the increased risk of thromboembolic events. Outcomes and management strategies for this condition are unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!